-+ 0.00%
-+ 0.00%
-+ 0.00%

HALOZYME THERAPEUTICS, INC : MORGAN STANLEY CUTS TARGET PRICE TO $62.00 FROM $73.00

Reuters·05/14/2025 10:29:14

Please log in to view news